United KingdomAdd to My Companies | Give a Referral for this Company | Print this Profile
The latest news, announcements and press releases from ADC Biotechnology Ltd.
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology (ADC Bio), a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs).
This follows an announcement by Sterling in December of a strategic investment into the ADC Bio business, with a view to acquisition in 2021.
We are pleased to announce that Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling) has made a new strategic partnership with our Company.
The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC Biotechnology in Q1 next year, subject to due diligence.
The businesses will work together to develop an integrated service offering for existing and potential customers, which combines ADC Bio’s expertise with Sterling’s high potency small molecule expertise.
Kevin Cook, CEO at Sterling, said: “This partnership is a really exciting one for both businesses. It will enable continued innovation around this fast-developing science, and in the future we hope that our combined expertise and targeted investment will be a strong competitive force in the race to find the latest generation of drugs in the oncology area.
“Sterling has always been, and will continue to be, focused on the services we can provide to our customers, to ensure they are ahead of the innovation curve and can develop the latest scientific breakthroughs to deliver better drugs for their patients. This partnership is a perfect example of this; some of the finest experts working together to achieve bigger and better things.”
Alan Raymond, Executive Chairman of ADC Bio, added: “The team at ADC Bio have been at the forefront of antibody drug bioconjugation and process development, supporting important advances in oncology with our clients in recent years. This strategic partnership will allow us to further develop this service with significant investment in the right areas of the business, which is great news for our employees and our customers. We are looking forward to working with the team at Sterling.”
This is the News section of the company profile page for ADC Biotechnology Ltd on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.